Diabetes medicines before surgery: checklist for SGLT2, insulin, GLP-1 and safe glucose monitoring – Dr. Moxit Shah, DM Endocrinology, Ahmedabad

Diabetes Medicines Before Surgery: Metformin, Insulin, SGLT2 and GLP-1 Safety Guide

By Dr. Moxit Shah, DM Endocrinology
Vishuddha Diabetes, Thyroid, Weight Loss Clinic, Ahmedabad

Medical information reviewed for publication: 19 November 2026.

“I have diabetes and am scheduled for an operation. Should I take my regular diabetes medicines before surgery?” This is an important question because the safest answer differs for metformin, insulin, glimepiride, dapagliflozin, empagliflozin, semaglutide and tirzepatide. Surgery, fasting and anaesthesia can change glucose requirements. Some medicines need to be withheld before an operation, whereas others—especially basal insulin in type 1 diabetes—must be covered by an individualized plan rather than simply omitted.

This guide explains how people with diabetes can prepare for an operation, endoscopy or other procedure requiring fasting. It draws on the American Diabetes Association (ADA) Standards of Care in Diabetes—2026 and current anaesthesia recommendations. It is a checklist for discussing your personal plan with the surgeon, anaesthetist and treating diabetes clinician—not an instruction to change doses independently.

Key takeaways: Tell the surgical team about every diabetes medicine you use. SGLT2 inhibitors such as dapagliflozin and empagliflozin generally need to be stopped at least three days before elective surgery. Insulin requires an individualized fasting plan. GLP-1 medicines do not have one universal stop rule: the anaesthesia team must evaluate gastrointestinal symptoms, treatment stage and procedure risk.

Why does diabetes medicine management change before surgery?

Before many operations, patients must not eat or drink for a defined period. At the same time, surgery and illness may increase stress hormones and push glucose higher. A person taking glucose-lowering medication while fasting may also develop hypoglycaemia. The goal is therefore to avoid both dangerous low glucose and excessive high glucose, while preventing complications such as diabetic ketoacidosis (DKA).

The ADA’s 2026 recommendations advise monitoring blood glucose before, during and after surgery and generally maintaining values between 100 and 180 mg/dL (5.6–10 mmol/L), with individual adjustment when necessary. The team may use different targets for specific patients or procedures.

Diabetes medicines before surgery: quick reference table

Medicine or class Typical perioperative consideration Why it matters
Metformin ADA 2026 advises holding on the day of surgery. Local protocols may differ; confirm with the anaesthesia team. Fasting, kidney function, contrast studies and acute illness can influence the plan.
Dapagliflozin, empagliflozin, canagliflozin (SGLT2 inhibitors) Usually stop at least 3 days before elective surgery. These medicines can increase the risk of perioperative ketoacidosis, sometimes with near-normal glucose.
Ertugliflozin (SGLT2 inhibitor) Usually stop at least 4 days before elective surgery. The recommended advance-hold period is longer.
Glimepiride, gliclazide (sulfonylureas) Typically not taken on the morning of an operation when fasting, as instructed by the team. These tablets can cause hypoglycaemia without food.
Other oral diabetes tablets ADA 2026 generally advises holding oral agents on the day of surgery; confirm the exact plan. Inpatient treatment and fasting requirements differ from usual home care.
Basal insulin (e.g., glargine, degludec, NPH) Do not stop automatically. A tailored dose and monitoring plan is needed; dose adjustment depends on insulin type and diabetes type. Too little insulin may cause marked hyperglycaemia or ketoacidosis; too much may cause hypoglycaemia.
Mealtime insulin (e.g., aspart, lispro, regular insulin) Requires instructions based on the meal and fasting status, current glucose and correction plan. Giving the usual food-related dose while fasting can cause low glucose.
Semaglutide, liraglutide, tirzepatide (GLP-1-based medicines) Individualized review. Many lower-risk patients may continue, but symptoms and anaesthesia risk can change the plan. Delayed gastric emptying may affect stomach contents during anaesthesia or deep sedation.

Important: This table summarizes broad professional guidance, not your prescription instructions. Procedure type, anaesthesia plan, kidney function, fasting time, medication formulation and the hospital’s protocol all matter. For instance, some 2026 cardiology guidance allows perioperative metformin continuation in selected patients while ADA’s diabetes hospital guideline recommends holding it on the day of surgery—so a single universal rule is inappropriate.

1. Metformin before surgery: Should you take it on the morning of the operation?

Metformin is among the most commonly used medicines for type 2 diabetes. The ADA 2026 hospital-care guideline advises withholding it on the day of surgery or a procedure. The treating team may also pay particular attention to kidney impairment, dehydration, serious acute illness or planned contrast imaging.

Not all guidelines use identical instructions. The newer perioperative cardiovascular guideline notes that continuing metformin can be reasonable in selected circumstances. The anaesthetist and hospital protocol should therefore determine the final plan, including when to resume it after oral intake and kidney function are satisfactory.

Read our metformin patient guide for information about its routine use and precautions.

2. Dapagliflozin and empagliflozin: Why is a 3-day pause important?

SGLT2 inhibitors include dapagliflozin, empagliflozin, canagliflozin and ertugliflozin. These medicines can help selected patients with type 2 diabetes, heart failure and chronic kidney disease. However, surgery and reduced food intake create special safety concerns.

Current ADA recommendations advise stopping dapagliflozin, empagliflozin and canagliflozin at least three days before elective surgery, and ertugliflozin at least four days before. The reason is the risk of euglycaemic diabetic ketoacidosis—a potentially serious condition in which glucose may not be as high as expected despite the presence of dangerous ketones and acidosis.

Do not rely on glucose alone to rule out DKA. Nausea, vomiting, abdominal pain, rapid breathing or unexplained severe illness around an operation requires urgent assessment. If your surgery is urgent and an SGLT2 drug was taken recently, inform the surgical team; an urgent procedure should not be independently delayed simply to complete the holding period.

Restart these medicines only after your treating team confirms that you are clinically stable, eating and drinking appropriately, and have no concerning ketoacidosis or other contraindications. For more information, see our SGLT2 inhibitor safety guide.

3. Insulin before surgery: Never stop without an individual plan

Insulin management is one of the most important parts of perioperative diabetes care. This is especially true in type 1 diabetes, where ongoing basal insulin is essential to prevent ketoacidosis even when the person is fasting.

Depending on the insulin preparation, current dosing and hospital protocol, a clinician may recommend a reduced preoperative basal dose or supervised insulin delivery during the procedure. The ADA 2026 guideline describes common approaches such as lowering certain long-acting basal analogues to around 75–80% of the usual dose, while NPH insulin may require a different adjustment. These are examples of clinical protocols—not instructions for patients to calculate or change doses themselves.

Mealtime insulin also requires an individualized plan. The usual dose intended to cover a meal is not automatically appropriate when that meal is skipped. The anaesthesia and diabetes teams should specify how to manage glucose monitoring and correction dosing.

For people using insulin pumps, an agreed plan is needed to continue pump therapy safely in an appropriate setting or to provide alternative insulin before the pump is disconnected. CGM may support trend monitoring, but during surgery it should not be the sole source of glucose measurements.

4. GLP-1 medicines before surgery: Ozempic, Wegovy, Mounjaro and Rybelsus

GLP-1 receptor agonists such as semaglutide and liraglutide, and dual GIP/GLP-1 medicines such as tirzepatide, can delay stomach emptying. This raises concerns about residual gastric contents during deep sedation or general anaesthesia, even after a patient has followed routine fasting instructions.

It is not correct to say that every patient must stop these medicines one week before surgery. Multisociety anaesthesia guidance and ADA 2026 recommendations support a personalized approach. Many lower-risk patients can continue treatment, but people who have nausea, vomiting, significant bloating, suspected delayed stomach emptying, or who are in the dose-escalation phase may need additional precautions.

Depending on the anaesthesia team’s assessment, options can include a 24-hour liquid-diet protocol before the procedure, modification of the anaesthesia plan, specialist evaluation or an individualized decision to withhold treatment. Do not begin a liquid diet, hold a dose, or restart a medicine without the surgical team’s instructions—particularly if you also use insulin or other diabetes medicines.

Tell your anaesthetist the exact medicine, dose, last dose date, recent dose changes and any digestive symptoms. More detail is available in our existing article on GLP-1 medicines before surgery or endoscopy.

5. What about glimepiride, gliclazide and other diabetes tablets?

Sulfonylureas, including glimepiride and gliclazide, stimulate insulin secretion. Taking them while fasting may cause hypoglycaemia, so they are generally withheld on the morning of surgery according to the clinician’s plan. The exact advice can depend on procedure timing and the product used.

Other oral medications, including DPP-4 inhibitors and pioglitazone, also require a review. The ADA advises withholding oral glucose-lowering drugs on the day of surgery; individual hospitals may use specific protocols or alternative inpatient strategies. Never assume that a diabetes combination tablet is safe to treat like a single-ingredient medicine: it may contain an SGLT2 inhibitor that needs an earlier pause.

What blood glucose and HbA1c levels are preferred before surgery?

For elective procedures, the ADA 2026 suggests a preoperative HbA1c below 8% within the preceding three months, when reasonably achievable, with individualized risk assessment. A recent continuous glucose monitoring summary may also help when available. HbA1c above 8% is not an automatic reason to cancel every operation; urgency and other risks should guide the decision.

During the perioperative period, a commonly recommended glucose range is 100–180 mg/dL. Glucose should be checked frequently by the clinical team, often every 2–4 hours during fasting, with adjustments according to the procedure and insulin regimen. Emergency and time-sensitive operations may go ahead even when long-term diabetes control is not optimal, with appropriate supervised management.

Our HbA1c targets guide explains why everyday HbA1c goals differ between patients.

Practical checklist: What should you tell the surgeon and anaesthetist?

  1. Your diabetes type: type 1, type 2, another type, or recent diagnosis.
  2. Every medicine and exact dose: include combination tablets, weekly injections, insulin pens or pumps, over-the-counter medicines and supplements.
  3. Timing: give the last dose taken and the usual administration schedule, especially for SGLT2 and GLP-1 medicines.
  4. Recent glucose data: bring HbA1c results, glucose records and CGM summaries if available.
  5. Relevant health conditions: kidney disease, heart disease, gastrointestinal symptoms, past DKA or severe hypoglycaemia.
  6. Fasting and eating plan: ask when to stop eating, how to manage medicines while fasting and when normal meals can resume.
  7. Emergency plan: know whom to contact if you vomit, develop low glucose, or your operation time changes.

If you become unwell before surgery or cannot keep fluids down, contact the clinical team. See our diabetes sick-day rules for related general education.

What happens after surgery? When can diabetes medicines be restarted?

Restarting medicines depends on the operation, hydration, kidney function, oral intake, infection risk and glucose readings. Do not automatically restart all medicines together after discharge. Your care team should give clear written instructions for what to take, when to resume each medicine and when to seek help.

Insulin may be necessary temporarily even for some people who do not ordinarily use it, particularly when surgical stress, steroids or restricted oral intake affect glucose. Patients using SGLT2 inhibitors should restart only when sufficiently recovered and the ketoacidosis risk has resolved.

Frequently asked questions

Should I take metformin the morning of surgery?

The ADA 2026 guideline advises holding it on the day of surgery, but other professional guidelines permit continuation in selected situations. Follow the personalized instructions given by your surgical and anaesthesia team.

How many days before surgery should I stop dapagliflozin or empagliflozin?

For elective surgery, professional guidance commonly recommends at least three days. Ertugliflozin is generally held for at least four days. Tell your team if the operation is urgent or if you took a recent dose.

Can I stop insulin because I am fasting?

Do not stop insulin without a plan. Basal insulin is particularly important in type 1 diabetes, even when no food is being eaten. An individual dose and glucose-monitoring schedule is essential.

Must I stop Ozempic or Mounjaro one week before every operation?

No universal one-week rule applies to everyone. Current guidance recommends considering digestive symptoms, dose changes, anaesthesia type, the procedure and other individual factors. The anaesthetist should decide the safest plan.

My HbA1c is 8.5%. Will my operation be cancelled?

Not necessarily. The ADA recommends working toward an HbA1c under 8% before elective surgery when appropriate, but decisions to proceed depend on urgency, current glucose, comorbidities and the surgical team’s judgment.

Can I trust my CGM alone during surgery?

No. Clinical teams should verify glucose with appropriate hospital blood-glucose measurements during surgery. Sensor readings can assist monitoring but are not a substitute for the required clinical checks.

What if my glucose becomes low while I am fasting for surgery?

Tell the clinical team immediately. Do not silently continue fasting with symptoms. Clinicians can treat low glucose safely and determine whether and how the procedure should proceed. If you have already been given a specific hypoglycaemia protocol, follow it and notify the team.

Can diabetes make healing after surgery slower?

Uncontrolled hyperglycaemia is associated with greater postoperative infection and healing risks. Appropriate glucose management, nutrition, wound care and follow-up can help improve outcomes. The risk depends on many factors beyond diabetes alone.

Diabetes care before surgery in Ahmedabad

If you have diabetes and are preparing for an operation, coordinated planning between your endocrinologist, surgeon and anaesthetist can reduce preventable medication problems. At Vishuddha Diabetes, Thyroid, Weight Loss Clinic, Dr. Moxit Shah, DM Endocrinology, provides individualized diabetes treatment review, insulin planning and metabolic assessment for patients who require specialist care.

Vishuddha Diabetes, Thyroid, Weight Loss Clinic
104–105, Elite Magnum, Bhuyangdev Cross Road, Opp. Utsav Elegance, Vardhmannagar Society, Ghatlodiya, Ahmedabad, Gujarat – 380061, India
Nearby areas: Memnagar and Naranpura
Dr. Moxit Shah, DM Endocrinology
Appointments: +91 99799 92797

Medical references

  1. American Diabetes Association. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 — perioperative glucose targets and medicine safety.
  2. ADA 2026 Section 16 clinical summary — medication holding guidance and preoperative care.
  3. American Society of Anesthesiologists. Drugs for Diabetes or Weight Loss: What to Know Before Surgery — current GLP-1 advice.
  4. 2026 ACC/AHA Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery — guidance on SGLT2 inhibitors and metformin.

Medical disclaimer: This article is general patient education, not a personalized perioperative medication or anaesthesia plan. Do not independently stop, increase or restart insulin or other diabetes medicines. Instructions differ by medicine, procedure, fasting requirements and individual health. Seek urgent medical assessment for suspected ketoacidosis, severe hypoglycaemia or serious illness.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *